metricas
covid
Buscar en
Vacunas
Toda la web
Inicio Vacunas Prevalence and risk factors of adverse effects after the first COVID-19 booster ...
Journal Information

Statistics

Follow this link to access the full text of the article

Original
Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece
Prevalencia y factores de riesgo de efectos adversos tras la primera dosis de refuerzo de COVID-19: Datos procedentes de Grecia
Petros Galanisa,
Corresponding author
pegalan@nurs.uoa.gr

Corresponding author.
, Aglaia Katsiroumpaa, Irene Vrakab, Vanessa Chrysagia, Olga Siskouc, Olympia Konstantakopouloud, Theodoros Katsoulase, Parisis Gallose, Daphne Kaitelidoud
a Clinical Epidemiology Laboratory, Faculty of Nursing, National and Kapodistrian University of Athens, Athens, Greece
b Department of Radiology, P. & A. Kyriakou Children's Hospital, Athens, Greece
c Department of Tourism Studies, University of Piraeus, Piraeus, Greece
d Center for Health Services Management and Evaluation, Faculty of Nursing, National and Kapodistrian University of Athens, Athens, Greece
e Faculty of Nursing, National and Kapodistrian University of Athens, Athens, Greece
Read
338
Times
was read the article
90
Total PDF
248
Total HTML
Share statistics
Article information
ISSN: 15769887
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 August 6 1 7
2024 July 26 14 40
2024 June 22 16 38
2024 May 19 14 33
2024 April 17 13 30
2024 March 22 12 34
2024 February 20 9 29
2024 January 14 0 14
2023 December 23 2 25
2023 November 9 0 9
2023 October 25 0 25
2023 September 10 0 10
2023 August 13 0 13
2023 July 16 4 20
2023 June 6 5 11
Show all

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos